Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities:
Net income including noncontrolling interests	$ 160,536	$ 142,631
Adjustments to reconcile income from operations to net cash from operating activities:
Depreciation and amortization	20,354	23,493
Share-based compensation expense related to equity classified awards	15,319	12,464
Amortization and write-off of program rights	218,626	199,517
Amortization of deferred carriage fees	4,401	4,401
Unrealized foreign currency transaction gain	(4,582)	(754)
Unrealized gain on derivative contracts, net	(13,984)	(11,486)
Amortization of deferred financing costs and discounts on indebtedness	1,881	2,282
Bad debt expense	914	961
Deferred income taxes	31,800	4,061
Other, net	(2,348)	278
Changes in assets and liabilities:
Accounts receivable, trade (including amounts due from related parties, net)	(17,877)	(15,980)
Prepaid expenses and other assets	(5,512)	(18,160)
Program rights and obligations, net	(248,642)	(211,280)
Income taxes payable	15,723	57,627
Deferred revenue	4,980	(11,104)
Deferred carriage fees, net	(1,610)	(430)
Accounts payable, accrued liabilities and other liabilities	(63,007)	(33,651)
Net cash provided by operating activities	116,972	144,870
Cash flows from investing activities:
Capital expenditures	(11,942)	(20,206)
Return of capital from investees	172	0
Investment in and loans to investees	(42,318)	(28,000)
Net cash used in investing activities	(54,088)	(48,206)
Cash flows from financing activities:
Principal payments on long-term debt	0	(55,500)
Deemed repurchases of restricted stock units	(15,354)	(12,796)
Purchase of treasury stock	(83,637)	(91,423)
Principal payments on capital lease obligations	(1,406)	(1,401)
Distributions to noncontrolling interests	(1,435)	(11,712)
Net cash used in financing activities	(101,832)	(172,832)
Net decrease in cash and cash equivalents from operations	(38,948)	(76,168)
Effect of exchange rate changes on cash and cash equivalents	9,365	(1,573)
Cash and cash equivalents at beginning of period	558,783	481,389
Cash and cash equivalents at end of period	$ 529,200	$ 403,648